ArticleDevelopmental dynamics : an official publication of the American Association of Anatomists2023

Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses.

Zachary D Michel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.